Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer
2005 · Journal of Clinical Pathology · 176 citations
https://doi.org/10.1136/jcp.2004.022772
M
M. Drijkoningen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
2.9K
Citations
31
h-index
49
i10-index
M. Drijkoningen is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Estrogen and related hormone effects. The author has an h-index of 31, co-authored 104 publications.
Papers by this author
worksPolysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
2008 · Journal of Clinical Oncology · 151 citations
https://doi.org/10.1200/jco.2007.13.4296
The E2F-Regulated Gene <i>Chk1</i> Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast Carcinomas
2007 · Cancer Research · 142 citations
https://doi.org/10.1158/0008-5472.can-06-3545
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive
2008 · Breast Cancer Research and Treatment · 91 citations
https://doi.org/10.1007/s10549-008-9914-7
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related
2005 · Breast Cancer Research and Treatment · 62 citations
https://doi.org/10.1007/s10549-004-8235-8
Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis
2010 · Journal of Clinical Oncology · 59 citations
https://doi.org/10.1200/jco.2009.26.4200
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat